Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v4-FR
Language French French
Date Updated 2022-03-22 2022-03-08
Drug Identification Number 00476420 00476420
Brand name COLY-MYCIN M PARENTERAL COLY-MYCIN M PARENTERAL
Common or Proper name COLY-MYCIN COLY-MYCIN
Company Name ERFA CANADA 2012 INC ERFA CANADA 2012 INC
Ingredients COLISTIN COLISTIN
Strength(s) 150MG 150MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size VIAL VIAL
ATC code J01XB J01XB
ATC description OTHER ANTIBACTERIALS OTHER ANTIBACTERIALS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2022-02-09 2022-02-09
Actual start date 2022-02-04 2022-02-04
Estimated end date 2022-03-14 2022-03-14
Actual end date 2022-03-16
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments